Search

Your search keyword '"Goldberg, Judith D."' showing total 251 results
Start Over Author "Goldberg, Judith D." Publication Year Range Last 10 years
251 results on '"Goldberg, Judith D."'

7. Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients

Author

Formenti, Silvia C, Hawtin, Rachael E, Dixit, Neha, Evensen, Erik, Lee, Percy, Goldberg, Judith D, Li, Xiaochun, Vanpouille-Box, Claire, Schaue, Dörthe, McBride, William H, and Demaria, Sandra

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Brain Disorders, Clinical Trials and Supportive Activities, Clinical Research, Breast Cancer, Cancer, Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, Breast Neoplasms, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Combined Modality Therapy, Female, Humans, Middle Aged, Programmed Cell Death 1 Receptor, Receptors, Antigen, T-Cell, Transforming Growth Factor beta, Young Adult, Immunotherapy, Radiotherapy, T cell receptor (TCR) signaling, Programmed Death-1, Oncology and carcinogenesis
Abstract

BackgroundWe previously reported the results of a multicentric prospective randomized trial of chemo-refractory metastatic breast cancer patients testing the efficacy of two doses of TGFβ blockade during radiotherapy. Despite a lack of objective responses to the combination, patients who received a higher dose of TGFβ blocking antibody fresolimumab had a better overall survival when compared to those assigned to lower dose (hazard ratio of 2.73, p = 0.039). They also demonstrated an improved peripheral blood mononuclear cell (PBMC) counts and increase in the CD8 central memory pool. We performed additional analysis on residual PBMC using single cell network profiling (SCNP).MethodsThe original trial randomized metastatic breast cancer patients to either 1 or 10 mg/kg of fresolimumab, every 3 weeks for 5 cycles, combined with radiotherapy to a metastatic site at week 1 and 7 (22.5 Gy given in 3 doses of 7.5 Gy). Trial immune monitoring results were previously reported. In 15 patients with available residual blood samples, additional functional studies were performed, and compared with data obtained in parallel from seven healthy female donors (HD): SCNP was applied to analyze T cell receptor (TCR) modulated signaling via CD3 and CD28 crosslinking and measurement of evoked phosphorylation of AKT and ERK in CD4 and CD8 T cell subsets defined by PD-1 expression.ResultsAt baseline, a significantly higher level of expression (p

Published
2019

8. A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Author

Mascarenhas, John, Kosiorek, Heidi E., Prchal, Josef T., Rambaldi, Alessandro, Berenzon, Dmitriy, Yacoub, Abdulraheem, Harrison, Claire N., McMullin, Mary Frances, Vannucchi, Alessandro M., Ewing, Joanne, O'Connell, Casey L., Kiladjian, Jean-Jacques, Mead, Adam J., Winton, Elliott F., Leibowitz, David S., De Stefano, Valerio, Arcasoy, Murat O., Kessler, Craig M., Catchatourian, Rosalind, Rondelli, Damiano, Silver, Richard T., Bacigalupo, Andrea, Nagler, Arnon, Kremyanskaya, Marina, Levine, Max F., Arango Ossa, Juan E., McGovern, Erin, Sandy, Lonette, Salama, Mohamad E., Najfeld, Vesna, Tripodi, Joseph, Farnoud, Noushin, Penson, Alexander V., Weinberg, Rona Singer, Price, Leah, Goldberg, Judith D., Barbui, Tiziano, Marchioli, Roberto, Tognoni, Gianni, Rampal, Raajit K., Mesa, Ruben A., Dueck, Amylou C., and Hoffman, Ronald

Published
2022
Full Text
View/download PDF

9. Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Author

Formenti, Silvia C, Lee, Percy, Adams, Sylvia, Goldberg, Judith D, Li, Xiaochun, Xie, Mike W, Ratikan, Josephine A, Felix, Carol, Hwang, Lin, Faull, Kym F, Sayre, James W, Hurvitz, Sara, Glaspy, John A, Comin-Anduix, Begoña, Demaria, Sandra, Schaue, Dörthe, and McBride, William H

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Breast Cancer, Radiation Oncology, Clinical Research, Clinical Trials and Supportive Activities, Cancer, Women's Health, 6.1 Pharmaceuticals, 6.5 Radiotherapy and other non-invasive therapies, Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Biomarkers, Breast Neoplasms, Combined Modality Therapy, Drug Monitoring, Female, Humans, Middle Aged, Molecular Targeted Therapy, Neoplasm Metastasis, Neoplasm Staging, Positron Emission Tomography Computed Tomography, Radiotherapy, Survival Analysis, Transforming Growth Factor beta, Treatment Outcome, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis
Abstract

Purpose: This study examined the feasibility, efficacy (abscopal effect), and immune effects of TGFβ blockade during radiotherapy in metastatic breast cancer patients.Experimental Design: Prospective randomized trial comparing two doses of TGFβ blocking antibody fresolimumab. Metastatic breast cancer patients with at least three distinct metastatic sites whose tumor had progressed after at least one line of therapy were randomized to receive 1 or 10 mg/kg of fresolimumab, every 3 weeks for five cycles, with focal radiotherapy to a metastatic site at week 1 (three doses of 7.5 Gy), that could be repeated to a second lesion at week 7. Research bloods were drawn at baseline, week 2, 5, and 15 to isolate PBMCs, plasma, and serum.Results: Twenty-three patients were randomized, median age 57 (range 35-77). Seven grade 3/4 adverse events occurred in 5 of 11 patients in the 1 mg/kg arm and in 2 of 12 patients in the 10 mg/kg arm, respectively. Response was limited to three stable disease. At a median follow up of 12 months, 20 of 23 patients are deceased. Patients receiving the 10 mg/kg had a significantly higher median overall survival than those receiving 1 mg/kg fresolimumab dose [hazard ratio: 2.73 with 95% confidence interval (CI), 1.02-7.30; P = 0.039]. The higher dose correlated with improved peripheral blood mononuclear cell counts and a striking boost in the CD8 central memory pool.Conclusions: TGFβ blockade during radiotherapy was feasible and well tolerated. Patients receiving the higher fresolimumab dose had a favorable systemic immune response and experienced longer median overall survival than the lower dose group. Clin Cancer Res; 24(11); 2493-504. ©2018 AACR.

Published
2018

13. Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography

Author

Gibson, Charlisa D., Bhatt, Alok, Deshwal, Himanshu, Li, Xiaochun, Goldberg, Judith D., Ko, Jane, and Condos, Rany

Subjects
Medical research -- Comparative analysis, Bacterial pneumonia -- Comparative analysis, Societies -- Comparative analysis, Pulmonary fibrosis -- Comparative analysis, Comorbidity -- Comparative analysis, Medical colleges -- Comparative analysis, CT imaging -- Comparative analysis, Associations, institutions, etc. -- Comparative analysis, Diagnostic imaging -- Comparative analysis, Medicine, Experimental -- Comparative analysis, Lung diseases, Obstructive -- Comparative analysis, Smoking -- Comparative analysis, Pneumonia -- Comparative analysis, Health
Abstract

Purpose Idiopathic Pulmonary Fibrosis is a progressive and fatal interstitial lung disease (ILD) characterized by a typical radiographic or histologic usual interstitial pneumonia (UIP) pattern. In 2018, diagnostic categories of UIP based on computed tomography patterns were revised by the Fleischner Society. The study aimed to describe differences in comorbidities and spirometry in ILD patients that were characterized by high-resolution computed tomography (HRCT) images as having a typical, probable, indeterminate, and alternative diagnosis of UIP. Methods We retrospectively studied 80 ILD patients from 2017 to 2019. Typical UIP was defined using the Fleischner Society diagnostic criteria for IPF. Atypical UIP was reached by consensus after a multidisciplinary clinical-radiological-pathological review of patient data. Baseline characteristics, comorbidities, and spirometry were compared among the four subgroups. Results Among 80 patients, 59% were male, 61% had a history of smoking, and the mean age was 67.7 ± 10 years (SD). A typical UIP pattern was more frequently observed among patients with chronic obstructive pulmonary disease (COPD) (p < 0.001) and pulmonary hypertension (p = 0.03). Of 30 patients with COPD, 14 had emphysema, while 10 had IPF. After adjusting for forced expiratory volume in one second (FEV.sub.1) in liters, change of FEV.sub.1% from baseline to 6-12 months, age, and sex, only COPD remained significantly associated with typical UIP (p = 0.018). Tobacco use was not significantly associated with any radiographic type (p = 0.199). Conclusion Typical UIP was prevalent among COPD/emphysema patients. Although smoking has a strong association with IPF, we did not find a significant association with smoking and typical UIP in our cohort., Author(s): Charlisa D. Gibson [sup.1], Alok Bhatt [sup.1], Himanshu Deshwal [sup.1], Xiaochun Li [sup.2], Judith D. Goldberg [sup.2], Jane Ko [sup.3], Rany Condos [sup.1] Author Affiliations: (1) grid.137628.9, 0000 0004 [...]

Published
2020
Full Text
View/download PDF

14. Evaluating Academic Scientists Collaborating in Team-Based Research

Author

Mazumdar, Madhu, Messinger, Shari, Finkelstein, Dianne M, Goldberg, Judith D, Lindsell, Christopher J, Morton, Sally C, Pollock, Brad H, Rahbar, Mohammad H, Welty, Leah J, and Parker, Robert A

Subjects
Curriculum and Pedagogy, Health Services and Systems, Health Sciences, Education, Prevention, Academic Medical Centers, Authorship, Cooperative Behavior, Employee Performance Appraisal, Faculty, Faculty, Medical, Humans, Research, Teaching, Biostatistics, Epidemiology, and Research Design (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium, Clinical Sciences, General & Internal Medicine, Curriculum and pedagogy, Health services and systems
Abstract

Criteria for evaluating faculty are traditionally based on a triad of scholarship, teaching, and service. Research scholarship is often measured by first or senior authorship on peer-reviewed scientific publications and being principal investigator on extramural grants. Yet scientific innovation increasingly requires collective rather than individual creativity, which traditional measures of achievement were not designed to capture and, thus, devalue. The authors propose a simple, flexible framework for evaluating team scientists that includes both quantitative and qualitative assessments. An approach for documenting contributions of team scientists in team-based scholarship, nontraditional education, and specialized service activities is also outlined. Although biostatisticians are used for illustration, the approach is generalizable to team scientists in other disciplines.The authors offer three key recommendations to members of institutional promotion committees, department chairs, and others evaluating team scientists. First, contributions to team-based scholarship and specialized contributions to education and service need to be assessed and given appropriate and substantial weight. Second, evaluations must be founded on well-articulated criteria for assessing the stature and accomplishments of team scientists. Finally, mechanisms for collecting evaluative data must be developed and implemented at the institutional level. Without these three essentials, contributions of team scientists will continue to be undervalued in the academic environment.

Published
2015

15. Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Author

Yacoub, Abdulraheem, Mascarenhas, John, Kosiorek, Heidi, Prchal, Josef T., Berenzon, Dmitry, Baer, Maria R., Ritchie, Ellen, Silver, Richard T., Kessler, Craig, Winton, Elliott, Finazzi, Maria Chiara, Rambaldi, Alessandro, Vannucchi, Alessandro M., Leibowitz, David, Rondelli, Damiano, Arcasoy, Murat O., Catchatourian, Rosalind, Vadakara, Joseph, Rosti, Vittorio, Hexner, Elizabeth, Kremyanskaya, Marina, Sandy, Lonette, Tripodi, Joseph, Najfeld, Vesna, Farnoud, Noushin, Papaemmanuil, Elli, Salama, Mohamed, Singer-Weinberg, Rona, Rampal, Raajit, Goldberg, Judith D., Barbui, Tiziano, Mesa, Ruben, Dueck, Amylou C., and Hoffman, Ronald

Published
2019
Full Text
View/download PDF

16. Peer review of clinical and translational research manuscripts: Perspectives from statistical collaborators

Author

Schulte, Phillip J., primary, Goldberg, Judith D., additional, Oster, Robert A., additional, Ambrosius, Walter T., additional, Bonner, Lauren Balmert, additional, Cabral, Howard, additional, Carter, Rickey E., additional, Chen, Ye, additional, Desai, Manisha, additional, Li, Dongmei, additional, Lindsell, Christopher J., additional, Pomann, Gina-Maria, additional, Slade, Emily, additional, Tosteson, Tor D., additional, Yu, Fang, additional, and Spratt, Heidi, additional

Published
2024
Full Text
View/download PDF

18. Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Author

Rampal, Raajit K., Mascarenhas, John O., Kosiorek, Heidi E., Price, Leah, Berenzon, Dmitriy, Hexner, Elizabeth, Abboud, Camille N., Kremyanskaya, Marina, Weinberg, Rona Singer, Salama, Mohamed E., Menghrajani, Kamal, Najfeld, Vesna, Sandy, Lonette, Heaney, Mark L., Levine, Ross L., Mesa, Ruben A., Dueck, Amylou C., Goldberg, Judith D., and Hoffman, Ronald

Published
2018
Full Text
View/download PDF

24. PTCy, Abatacept, and Short Course of Tacrolimus for GvHD Prevention Following Haploidentical Transplantation

Author

Al-Homsi, A Samer, primary, Cirrone, Frank, additional, Wo, Stephanie, additional, Cole, Kelli, additional, Suarez-Londono, J Andres, additional, Gardner, Sharon L, additional, Hsu, Jingmei, additional, Stocker, Kelsey, additional, Bruno, Benedetto, additional, Goldberg, Judith D., additional, Levinson, Benjamin A, additional, and Abdul-Hay, Maher, additional

Published
2023
Full Text
View/download PDF

27. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy

Author

Jhaveri, Komal, Teplinsky, Eleonora, Silvera, Deborah, Valeta-Magara, Amanda, Arju, Rezina, Giashuddin, Shah, Sarfraz, Yasmeen, Alexander, Melissa, Darvishian, Farbod, Levine, Paul H., Hashmi, Salman, Zolfaghari, Ladan, Hoffman, Heather J., Singh, Baljit, Goldberg, Judith D., Hochman, Tsivia, Formenti, Silvia, Esteva, Francisco J., Moran, Meena S., and Schneider, Robert J.

Published
2016
Full Text
View/download PDF

29. Case Series of Men with the Germline APCI1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer

Author

Economides, Minas P., Nakazawa, Mari, Lee, Jonathan W., Li, Xiaochun, Hollifield, Lucas, Chambers, Rachelle, Sarfaty, Michal, Goldberg, Judith D., Antonarakis, Emmanuel S., and Wise, David R.

Abstract

•The APCI1307K germline variant is present in 7% of the Ashkenazi Jewish population and is associated with the development of several malignancies.•We report a case series of advanced prostate cancer patients with the germline APCI1307K mutation.•Prevalence of aggressive variant prostate cancer (driven by increased treatment-emergent neuroendocrine prostate cancer rate) in patients with the germline APCI1307K mutation is increased when compared to patients with prostate cancer and canonical APCframeshift mutations.•Prevalence of ARgenomic alterations in this cohort is lower than in unselected men with metastatic prostate cancer identified from cBioPortal database.

Published
2024
Full Text
View/download PDF

31. Data from Endothelin Receptor Type B Gene Promoter Hypermethylation in Salivary Rinses Is Independently Associated with Risk of Oral Cavity Cancer and Premalignancy

Author

Pattani, Kavita Malhotra, primary, Zhang, Zhe, primary, Demokan, Semra, primary, Glazer, Chad, primary, Loyo, Myriam, primary, Goodman, Steven, primary, Sidransky, David, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Bowne, Helen Yoo, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

33. Perspective on This Article from Endothelin Receptor Type B Gene Promoter Hypermethylation in Salivary Rinses Is Independently Associated with Risk of Oral Cavity Cancer and Premalignancy

Author

Pattani, Kavita Malhotra, primary, Zhang, Zhe, primary, Demokan, Semra, primary, Glazer, Chad, primary, Loyo, Myriam, primary, Goodman, Steven, primary, Sidransky, David, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Bowne, Helen Yoo, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 1 from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Author

Adams, Sylvia, primary, Kozhaya, Lina, primary, Martiniuk, Frank, primary, Meng, Tze-Chiang, primary, Chiriboga, Luis, primary, Liebes, Leonard, primary, Hochman, Tsivia, primary, Shuman, Nicholas, primary, Axelrod, Deborah, primary, Speyer, James, primary, Novik, Yelena, primary, Tiersten, Amy, primary, Goldberg, Judith D., primary, Formenti, Silvia C., primary, Bhardwaj, Nina, primary, Unutmaz, Derya, primary, and Demaria, Sandra, primary

Published
2023
Full Text
View/download PDF

36. Data from Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Author

Formenti, Silvia C., primary, Lee, Percy, primary, Adams, Sylvia, primary, Goldberg, Judith D., primary, Li, Xiaochun, primary, Xie, Mike W., primary, Ratikan, Josephine A., primary, Felix, Carol, primary, Hwang, Lin, primary, Faull, Kym F., primary, Sayre, James W., primary, Hurvitz, Sara, primary, Glaspy, John A., primary, Comin-Anduix, Begoña, primary, Demaria, Sandra, primary, Schaue, Dörthe, primary, and McBride, William H., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Data from EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions

Author

Schussel, Juliana, primary, Zhou, Xian Chong, primary, Zhang, Zhe, primary, Pattani, Kavita, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Brait, Mariana, primary, Li, Ryan, primary, Yoo Bowne, Helen, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 1 from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Author

Adams, Sylvia, primary, Kozhaya, Lina, primary, Martiniuk, Frank, primary, Meng, Tze-Chiang, primary, Chiriboga, Luis, primary, Liebes, Leonard, primary, Hochman, Tsivia, primary, Shuman, Nicholas, primary, Axelrod, Deborah, primary, Speyer, James, primary, Novik, Yelena, primary, Tiersten, Amy, primary, Goldberg, Judith D., primary, Formenti, Silvia C., primary, Bhardwaj, Nina, primary, Unutmaz, Derya, primary, and Demaria, Sandra, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table 2 from EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions

Author

Schussel, Juliana, primary, Zhou, Xian Chong, primary, Zhang, Zhe, primary, Pattani, Kavita, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Brait, Mariana, primary, Li, Ryan, primary, Yoo Bowne, Helen, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure Legend from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Author

Adams, Sylvia, primary, Kozhaya, Lina, primary, Martiniuk, Frank, primary, Meng, Tze-Chiang, primary, Chiriboga, Luis, primary, Liebes, Leonard, primary, Hochman, Tsivia, primary, Shuman, Nicholas, primary, Axelrod, Deborah, primary, Speyer, James, primary, Novik, Yelena, primary, Tiersten, Amy, primary, Goldberg, Judith D., primary, Formenti, Silvia C., primary, Bhardwaj, Nina, primary, Unutmaz, Derya, primary, and Demaria, Sandra, primary

Published
2023
Full Text
View/download PDF

41. S1-4 from Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Author

Formenti, Silvia C., primary, Lee, Percy, primary, Adams, Sylvia, primary, Goldberg, Judith D., primary, Li, Xiaochun, primary, Xie, Mike W., primary, Ratikan, Josephine A., primary, Felix, Carol, primary, Hwang, Lin, primary, Faull, Kym F., primary, Sayre, James W., primary, Hurvitz, Sara, primary, Glaspy, John A., primary, Comin-Anduix, Begoña, primary, Demaria, Sandra, primary, Schaue, Dörthe, primary, and McBride, William H., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 1 from EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions

Author

Schussel, Juliana, primary, Zhou, Xian Chong, primary, Zhang, Zhe, primary, Pattani, Kavita, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Brait, Mariana, primary, Li, Ryan, primary, Yoo Bowne, Helen, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

43. Data from Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

Author

Firoz, Elnaz F., primary, Warycha, Melanie, primary, Zakrzewski, Jan, primary, Pollens, Danuta, primary, Wang, Guimin, primary, Shapiro, Richard, primary, Berman, Russell, primary, Pavlick, Anna, primary, Manga, Prashiela, primary, Ostrer, Harry, primary, Celebi, Julide Tok, primary, Kamino, Hideko, primary, Darvishian, Farbod, primary, Rolnitzky, Linda, primary, Goldberg, Judith D., primary, Osman, Iman, primary, and Polsky, David, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table S1 from Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

Author

Firoz, Elnaz F., primary, Warycha, Melanie, primary, Zakrzewski, Jan, primary, Pollens, Danuta, primary, Wang, Guimin, primary, Shapiro, Richard, primary, Berman, Russell, primary, Pavlick, Anna, primary, Manga, Prashiela, primary, Ostrer, Harry, primary, Celebi, Julide Tok, primary, Kamino, Hideko, primary, Darvishian, Farbod, primary, Rolnitzky, Linda, primary, Goldberg, Judith D., primary, Osman, Iman, primary, and Polsky, David, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 1 from EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions

Author

Schussel, Juliana, primary, Zhou, Xian Chong, primary, Zhang, Zhe, primary, Pattani, Kavita, primary, Bermudez, Francisco, primary, Jean-Charles, Germain, primary, McCaffrey, Thomas, primary, Padhya, Tapan, primary, Phelan, Joan, primary, Spivakovsky, Silvia, primary, Brait, Mariana, primary, Li, Ryan, primary, Yoo Bowne, Helen, primary, Goldberg, Judith D., primary, Rolnitzky, Linda, primary, Robbins, Miriam, primary, Kerr, A. Ross, primary, Sirois, David, primary, and Califano, Joseph A., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figures 1-8, Tables 1-7 from High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance

Author

Simpson, Natalie E., primary, Lambert, W. Marcus, primary, Watkins, Renecia, primary, Giashuddin, Shah, primary, Huang, S. Joseph, primary, Oxelmark, Ellinor, primary, Arju, Rezina, primary, Hochman, Tsivia, primary, Goldberg, Judith D., primary, Schneider, Robert J., primary, Reiz, Luiz Fernando Lima, primary, Soares, Fernando Augusto, primary, Logan, Susan K., primary, and Garabedian, Michael J., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results